BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22237615)

  • 1. [ADD psychosis: treatment with antipsychotics and methylphenidate?].
    Blom JD; Kooij JJ
    Tijdschr Psychiatr; 2012; 54(1):89-93. PubMed ID: 22237615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Response to 'ADD psychosis: treatment with antipsychotics and methylphenidate?'].
    Vergouwen T; Gorissen-Van Eenige M
    Tijdschr Psychiatr; 2012; 54(3):308; author reply 309. PubMed ID: 22422425
    [No Abstract]   [Full Text] [Related]  

  • 3. Attention-deficit hyperactivity disorder and comorbid psychosis: a review and two clinical presentations.
    Pine DS; Klein RG; Lindy DC; Marshall RD
    J Clin Psychiatry; 1993 Apr; 54(4):140-5. PubMed ID: 8098031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of patients with schizophrenia successive to childhood attention deficit hyperactivity disorder (ADHD).
    Elman I; Sigler M; Kronenberg J; Lindenmayer JP; Doron A; Mendlovic S; Gaoni B
    Isr J Psychiatry Relat Sci; 1998; 35(4):280-6. PubMed ID: 9988985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M; Uekermann J; Wiltfang J; Kis B
    Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.
    Levin FR; Evans SM; Brooks DJ; Garawi F
    Drug Alcohol Depend; 2007 Feb; 87(1):20-9. PubMed ID: 16930863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone-to-methylphenidate switch reaction in children: three cases.
    Sabuncuoglu O
    J Psychopharmacol; 2007 Mar; 21(2):216-9. PubMed ID: 17329303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotic disorders comorbid with attention-deficit hyperactivity disorder: an important knowledge gap.
    Levy E; Traicu A; Iyer S; Malla A; Joober R
    Can J Psychiatry; 2015 Mar; 60(3 Suppl 2):S48-52. PubMed ID: 25886680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antipsychotic agents and stimulants: a judicious combination?].
    de Jong MH; Eussen ML; van Gool AR
    Tijdschr Psychiatr; 2010; 52(1):57-61. PubMed ID: 20054798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturalistic long-term use of methylphenidate in bipolar disorder.
    Lydon E; El-Mallakh RS
    J Clin Psychopharmacol; 2006 Oct; 26(5):516-8. PubMed ID: 16974196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating adult attention deficit hyperactivity disorder in hospitalized psychiatric patients.
    Castaneda R; Levy R; Hazzi C; Ross S; Roman W; Hamid H
    Gen Hosp Psychiatry; 2008; 30(6):572-7. PubMed ID: 19061685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond methylphenidate: nonstimulant medications for youth with ADHD.
    Wood JG; Crager JL; Delap CM; Heiskell KD
    J Atten Disord; 2007 Nov; 11(3):341-50. PubMed ID: 17932386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
    Levin FR; Evans SM; Brooks DJ; Kalbag AS; Garawi F; Nunes EV
    Drug Alcohol Depend; 2006 Feb; 81(2):137-48. PubMed ID: 16102908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
    Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case of a 67-year-old woman diagnosed with ADHD successfully treated with methylphenidate.
    da Silva MA; Louza M
    J Atten Disord; 2008 May; 11(6):623. PubMed ID: 18417727
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder.
    Somoza EC; Winhusen TM; Bridge TP; Rotrosen JP; Vanderburg DG; Harrer JM; Mezinskis JP; Montgomery MA; Ciraulo DA; Wulsin LR; Barrett JA
    J Addict Dis; 2004; 23(1):77-92. PubMed ID: 15077842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.